semaglutide eye damage A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Semaglutide Linked to Increased Risk

Patients who discontinue their medication tend to regain a significant portion of the lost weight within 12 months, as the biological signals that drive appetite and weight regain return

An excess of belly fat can also lead to hypertension, insulin resistance, and cardiovascular disease

It was approved by the FDA in January 2010

Gala Health Review blog/Gala Health Review on GLP-1 Compare

However, a single case report described worsening of paranoid delusions in a patient with diabetes and schizophrenia treated with ziprasidone who was initiated on semaglutide 1 mg for weight loss

Making (or eating) homemade peanut butter cookies